Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

Biogen, Inc. - Product Pipeline Review – 2016, Market Analysis and Forecast Report

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps .
MarketsandMarkets™ | 04.04.2016

Biogen, Inc. - Product Pipeline Review - 2016 Size and Share Published in 2016-02-29 Available for US$ 1500 at Researchmoz.us

Description

Global Markets Directs, Biogen, Inc. - Product Pipeline
Review - 2016, provides an overview of the Biogen, Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Biogen, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=685378

Scope


- The report provides a snapshot of the pipeline therapeutic landscape of Biogen, Inc.

- The report provides overview of Biogen, Inc. including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses Biogen, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features Biogen, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Biogen, Inc.s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Biogen, Inc.

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Biogen, Inc.s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=685378

Table of Content


Table of Contents 2

List of Tables 6

List of Figures 6

Biogen, Inc. Snapshot 7

Biogen, Inc. Overview 7

Key Information 7

Key Facts 7

Biogen, Inc. - Research and Development Overview 8

Key Therapeutic Areas 8

Biogen, Inc. - Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products - Monotherapy 12

Pipeline Products - Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Pipeline Products - Out-Licensed Products 16

Out-Licensed Products/Combination Treatment Modalities 17

Biogen, Inc. - Pipeline Products Glance 18

Biogen, Inc. - Late Stage Pipeline Products 18

Pre-Registration Products/Combination Treatment Modalities 18

Phase III Products/Combination Treatment Modalities 19

Biogen, Inc. - Clinical Stage Pipeline Products 20

Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz


ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/

For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20





Img of MarketsandMarkets™
About the tenderer: MarketsandMarkets™

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports.